Discovery & Development

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

Environmentally friendly catalyst technologies are on the rise in pharma.

What difference can taste-masking make to the patient experience?

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

This is the story of how DNDi put forward a new model for collaborative, open science.

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2